Cargando…
Protocol for a multicentre, randomised, parallel-control, superiority trial comparing administration of clotting factor concentrates with a standard massive haemorrhage protocol in severely bleeding trauma patients: the FiiRST 2 trial (a 2020 EAST multicentre trial)
INTRODUCTION: Acute traumatic coagulopathy (ATC) in bleeding trauma patients increase in-hospital mortality. Fibrinogen concentrate (FC) and prothrombin complex concentrate (PCC) are two purified concentrates of clotting factors that have been used to treat ATC. However, there is a knowledge gap on...
Autores principales: | da Luz, Luis Teodoro, Callum, Jeannie, Beckett, Andrew, Hucke, Hans-Peter, Carroll, Jo, Grewal, Deep, Schwartz, Bruce, Peng, Henry, Engels, Paul T, Parry, Neil, Petrosoniak, Andrew, Tien, Homer, Nathens, Avery B, Scales, Damon, Karkouti, Keyvan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8420689/ https://www.ncbi.nlm.nih.gov/pubmed/34479938 http://dx.doi.org/10.1136/bmjopen-2021-051003 |
Ejemplares similares
-
Protocol for a phase III, non-inferiority, randomised comparison of a new fibrinogen concentrate versus cryoprecipitate for treating acquired hypofibrinogenaemia in bleeding cardiac surgical patients: the FIBRES trial
por: Karkouti, Keyvan, et al.
Publicado: (2018) -
Freeze-dried plasma for major trauma – Systematic review and meta-analysis
por: Mok, Garrick, et al.
Publicado: (2021) -
The association of prothrombin complex concentrates with postoperative outcomes in cardiac surgery: an observational substudy of the FIBRES randomized controlled trial
por: Bartoszko, Justyna, et al.
Publicado: (2021) -
Comparison of 4-Factor Prothrombin Complex Concentrate With Frozen Plasma for Management of Hemorrhage During and After Cardiac Surgery: A Randomized Pilot Trial
por: Karkouti, Keyvan, et al.
Publicado: (2021) -
Inased (inhaled sedation in ICU) trial protocol: a multicentre randomised open-label trial
por: Bailly, Pierre, et al.
Publicado: (2021)